DNDN (Dendreon Corp)

We wrote about DNDN in early December, after they released news of a royalty sale for $125 million. Sometimes that can be the sign of a desperate company, especially one that has been burning through cash at a high rate. But we thought the opposite and that the calls would be a nice play going forward, as we wrote here.

DNDN
DNDN

Turns out those have been quite a profitable trade, as DNDN has surged more then 50% from the December lows closing at $13.31 today. It's anyones guess if this current 3 day monster run continues on the pre-announcement of "better-than-forecast fourth quarter 2011 revenue ". DNDN still has a questionable future, and will be in trouble if its only revenue driving drug fails.

For now, its best to play the hype, and lock in profits when you can. Its usually the people looking at the chart, waiting for a retest of the stocks highs, that are holding the bag a few weeks later wondering what happened.

Figure short term top of $15-17 to lock in profits, and hold some calls for possible $20 test.

dndn 1-9
dndn 1-9

 

Profile photo of jimmybobJimmyBob (Scott)has been trading equities for over 15 years, a majority of which were OTC micro-cap stocks. He started trading high risk stock options over the past 7 years, and has proven winning trades in excess of 15,000%.

As one of the Co-Founders of optionmillionaires.com, Scott enjoys sharing his knowledge with other investors through timely blog posts, daily watch lists in the forum, weekly webinars, and helpful advice within the chatroom.

More Posts by JB: View All | Private Twitter Feed: Access Now! (For Diamond Members)

Leave a Reply